Skip to content

3D Mapping Versus Conventional Ablation in AVNRT

Three-Dimensional Electroanatomical Mapping Versus Conventional Fluoroscopy-Guided Slow Pathway Ablation for Typical Atrioventricular Nodal Re-Entrant Tachycardia: A Prospective Randomized Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07630480
Acronym
MAP-AVNRT
Enrollment
80
Registered
2026-06-05
Start date
2023-12-30
Completion date
2025-11-23
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Nodal Reentry Tachycardia, Supraventricular Tachycardia (SVT)

Keywords

AVNRT, Catheter Ablation, Electrophysiology, Three-Dimensional Mapping, Electroanatomical Mapping, Fluoroscopy, Slow Pathway Ablation

Brief summary

This prospective randomized interventional study compared conventional fluoroscopy-guided slow pathway ablation versus three-dimensional electroanatomical mapping-guided ablation in patients with electrophysiologically confirmed typical atrioventricular nodal re-entrant tachycardia (AVNRT). A total of 108 patients were screened for eligibility, of whom 80 eligible patients were randomized in a 1:1 ratio to either conventional fluoroscopic ablation or 3D mapping-guided ablation. Following post-randomization dropouts, the final analysis included 38 patients in the conventional group and 36 patients in the 3D mapping group. The study evaluated fluoroscopy exposure, procedural efficacy, complete slow pathway elimination, procedural success, complications, and arrhythmia recurrence during follow-up.

Detailed description

Atrioventricular nodal re-entrant tachycardia (AVNRT) is one of the most common forms of paroxysmal supraventricular tachycardia. Catheter ablation targeting the slow AV nodal pathway is considered definitive therapy with high procedural success rates. Conventional fluoroscopy-guided ablation mainly relies on anatomical landmarks and intracardiac electrogram interpretation. However, fluoroscopy exposure remains an important concern for both patients and operators. Three-dimensional electroanatomical mapping systems allow detailed reconstruction of the triangle of Koch and facilitate substrate-guided ablation using voltage, activation, and fractionated electrogram mapping techniques. These systems may reduce fluoroscopy exposure and improve procedural precision and efficacy. This prospective randomized two-arm interventional study was conducted at the Cardiology Department, Kafr El-Sheikh University Hospital, between December 2023 and November 2025. A total of 108 consecutive patients with symptomatic supraventricular tachycardia suggestive of AVNRT were screened for eligibility. Following assessment according to predefined inclusion and exclusion criteria, 80 eligible patients with electrophysiologically confirmed typical AVNRT were enrolled and randomized in a 1:1 ratio to either conventional fluoroscopy-guided slow pathway ablation (Conventional group, n = 40) or three-dimensional electroanatomical mapping-guided slow pathway ablation (3D group, n = 40). During the study period, post-randomization dropouts and exclusions occurred in both groups. Consequently, the final analysis included 38 patients in the conventional ablation group and 36 patients in the 3D mapping-guided ablation group. In the conventional arm, ablation was performed using standard fluoroscopic anatomical landmarks and intracardiac electrogram criteria within the triangle of Koch. In the 3D mapping arm, high-density electroanatomical mapping using CARTO or EnSite X systems was performed with integrated voltage, activation, and fractionated electrogram mapping to identify optimal ablation targets. Primary outcomes included fluoroscopy time, fluoroscopy dose, complete slow pathway elimination, and procedural success defined as non-inducibility of sustained AVNRT after ablation. Secondary outcomes included total procedure duration, number and duration of radiofrequency applications, complications, recurrence during follow-up, hospital stay duration, need for redo ablation, and predictors of complete slow pathway elimination.

Interventions

PROCEDUREConventional Slow Pathway Ablation

Conventional fluoroscopy-guided catheter ablation of the slow AV nodal pathway using anatomical landmarks and intracardiac electrogram criteria within the triangle of Koch.

PROCEDURE3D Electroanatomical Mapping-Guided Ablation

Three-dimensional electroanatomical mapping-guided catheter ablation of the slow AV nodal pathway using CARTO or EnSite X systems with voltage and activation mapping guidance.

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessment and follow-up evaluation were performed by investigators blinded to treatment allocation.

Intervention model description

Eligible patients with electrophysiologically confirmed typical AVNRT were randomized in a 1:1 ratio to either conventional fluoroscopy-guided slow pathway ablation or three-dimensional electroanatomical mapping-guided ablation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sustained symptomatic supraventricular tachycardia with surface ECG features highly suggestive of atrioventricular nodal re-entrant tachycardia (AVNRT). * Electrophysiologically confirmed typical (slow-fast) AVNRT during the index electrophysiology study. * Ability to provide written informed consent.

Exclusion criteria

* Coexisting arrhythmia requiring concurrent catheter ablation during the same procedure. * Non-inducible AVNRT at the time of electrophysiological study. * Antiarrhythmic drug use within 48 hours before the procedure or ongoing amiodarone therapy. * Hemodynamic instability precluding safe catheter manipulation. * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Total Fluoroscopy Radiation Dose During Catheter AblationAt completion of the index ablation procedureTotal fluoroscopy radiation dose measured during the catheter ablation procedure, reported in mGy.
Total Fluoroscopy Exposure Time During Catheter AblationAt completion of the index ablation procedureTotal duration of fluoroscopy exposure during the catheter ablation procedure, reported in minutes.

Secondary

MeasureTime frameDescription
Number of Participants With Complete Slow Pathway EliminationAt completion of the index ablation procedureComplete abolition of slow pathway conduction and disappearance of the anterograde AH jump following catheter ablation.
Number of Participants with Acute Procedural SuccessAt completion of the index ablation procedureAcute procedural success defined as non-inducibility of sustained AVNRT after catheter ablation under baseline conditions and following isoproterenol infusion.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026